3.24.0.1 html 214 427 1 false 76 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.pumabiotechnology.com/20231231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-balance-sheets- Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-statements-of-comprehensive-income-loss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficit- Consolidated Statements of Stockholders' Equity (Deficit) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals) Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-statements-of-stockholders-equity-deficit-parentheticals Consolidated Statements of Stockholders' Equity (Deficit) (Parentheticals) Statements 7 false false R8.htm 007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.pumabiotechnology.com/20231231/role/statement-consolidated-statements-of-cash-flows- Consolidated Statements of Cash Flows Statements 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995454 - Disclosure - Note 1 - Business and Basis of Presentation Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-1-business-and-basis-of-presentation Note 1 - Business and Basis of Presentation Notes 10 false false R11.htm 995455 - Disclosure - Note 2 - Significant Accounting Policies Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies Note 2 - Significant Accounting Policies Notes 11 false false R12.htm 995456 - Disclosure - Note 3 - Accounts Receivable Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-3-accounts-receivable Note 3 - Accounts Receivable Notes 12 false false R13.htm 995457 - Disclosure - Note 4 - Prepaid Expenses and Other Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-4-prepaid-expenses-and-other Note 4 - Prepaid Expenses and Other Notes 13 false false R14.htm 995458 - Disclosure - Note 5 - Property and Equipment Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-5-property-and-equipment Note 5 - Property and Equipment Notes 14 false false R15.htm 995459 - Disclosure - Note 6 - Leases Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases- Note 6 - Leases Notes 15 false false R16.htm 995460 - Disclosure - Note 7 - Intangible Assets Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-7-intangible-assets Note 7 - Intangible Assets Notes 16 false false R17.htm 995461 - Disclosure - Note 8 - Accrued Expenses Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-8-accrued-expenses Note 8 - Accrued Expenses Notes 17 false false R18.htm 995462 - Disclosure - Note 9 - Debt Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt- Note 9 - Debt Notes 18 false false R19.htm 995463 - Disclosure - Note 10 - Stockholders' Equity (Deficit) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit Note 10 - Stockholders' Equity (Deficit) Notes 19 false false R20.htm 995464 - Disclosure - Note 11 - 401(k) Savings Plan Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-11-401k-savings-plan Note 11 - 401(k) Savings Plan Notes 20 false false R21.htm 995465 - Disclosure - Note 12 - Income Taxes Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes Note 12 - Income Taxes Notes 21 false false R22.htm 995466 - Disclosure - Note 13 - Commitments and Contingencies Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-13-commitments-and-contingencies Note 13 - Commitments and Contingencies Notes 22 false false R23.htm 995467 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.pumabiotechnology.com/20231231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies 23 false false R24.htm 995468 - Disclosure - Note 2 - Significant Accounting Policies (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-tables Note 2 - Significant Accounting Policies (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies 24 false false R25.htm 995469 - Disclosure - Note 3 - Accounts Receivable (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-3-accounts-receivable-tables Note 3 - Accounts Receivable (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-3-accounts-receivable 25 false false R26.htm 995470 - Disclosure - Note 4 - Prepaid Expenses and Other (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-4-prepaid-expenses-and-other-tables Note 4 - Prepaid Expenses and Other (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-4-prepaid-expenses-and-other 26 false false R27.htm 995471 - Disclosure - Note 5 - Property and Equipment (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-5-property-and-equipment-tables Note 5 - Property and Equipment (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-5-property-and-equipment 27 false false R28.htm 995472 - Disclosure - Note 6 - Leases (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases-tables Note 6 - Leases (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases- 28 false false R29.htm 995473 - Disclosure - Note 7 - Intangible Assets (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-7-intangible-assets-tables Note 7 - Intangible Assets (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-7-intangible-assets 29 false false R30.htm 995474 - Disclosure - Note 8 - Accrued Expenses (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-8-accrued-expenses-tables Note 8 - Accrued Expenses (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-8-accrued-expenses 30 false false R31.htm 995475 - Disclosure - Note 9 - Debt (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-tables Note 9 - Debt (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt- 31 false false R32.htm 995476 - Disclosure - Note 10 - Stockholders' Equity (Deficit) (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables Note 10 - Stockholders' Equity (Deficit) (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit 32 false false R33.htm 995477 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-tables Note 12 - Income Taxes (Tables) Tables http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes 33 false false R34.htm 995478 - Disclosure - Note 1 - Business and Basis of Presentation (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-1-business-and-basis-of-presentation-details-textual Note 1 - Business and Basis of Presentation (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-1-business-and-basis-of-presentation 34 false false R35.htm 995479 - Disclosure - Note 2 - Significant Accounting Policies (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-details-textual Note 2 - Significant Accounting Policies (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-tables 35 false false R36.htm 995480 - Disclosure - Note 2 - Significant Accounting Policies - Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-potentially-dilutive-securities-not-included-in-calculation-of-diluted-net-loss-per-share-details Note 2 - Significant Accounting Policies - Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details) Details 36 false false R37.htm 995481 - Disclosure - Note 2 - Significant Accounting Policies - Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-assets-measured-at-fair-value-on-recurring-basis-details Note 2 - Significant Accounting Policies - Assets Measured at Fair Value on Recurring Basis (Details) Details 37 false false R38.htm 995482 - Disclosure - Note 2 - Significant Accounting Policies - Summary of Cash Equivalents and Short-term Investment (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-summary-of-cash-equivalents-and-shortterm-investment-details Note 2 - Significant Accounting Policies - Summary of Cash Equivalents and Short-term Investment (Details) Details 38 false false R39.htm 995483 - Disclosure - Note 2 - Significant Accounting Policies - Inventory Balance (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-inventory-balance-details Note 2 - Significant Accounting Policies - Inventory Balance (Details) Details 39 false false R40.htm 995484 - Disclosure - Note 2 - Significant Accounting Policies - Other Current Assets (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-2-significant-accounting-policies-other-current-assets-details Note 2 - Significant Accounting Policies - Other Current Assets (Details) Details 40 false false R41.htm 995485 - Disclosure - Note 3 - Accounts Receivable (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-3-accounts-receivable-details-textual Note 3 - Accounts Receivable (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-3-accounts-receivable-tables 41 false false R42.htm 995486 - Disclosure - Note 3 - Accounts Receivable - Schedule of Accounts Receivable, Net (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-3-accounts-receivable-schedule-of-accounts-receivable-net-details Note 3 - Accounts Receivable - Schedule of Accounts Receivable, Net (Details) Details 42 false false R43.htm 995487 - Disclosure - Note 4 - Prepaid Expenses and Other - Prepaid Expenses and Other (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-4-prepaid-expenses-and-other-prepaid-expenses-and-other-details Note 4 - Prepaid Expenses and Other - Prepaid Expenses and Other (Details) Details 43 false false R44.htm 995488 - Disclosure - Note 5 - Property and Equipment (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-5-property-and-equipment-details-textual Note 5 - Property and Equipment (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-5-property-and-equipment-tables 44 false false R45.htm 995489 - Disclosure - Note 5 - Property and Equipment - Property and Equipment, Net (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-5-property-and-equipment-property-and-equipment-net-details Note 5 - Property and Equipment - Property and Equipment, Net (Details) Details 45 false false R46.htm 995490 - Disclosure - Note 6 - Leases (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases-details-textual Note 6 - Leases (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases-tables 46 false false R47.htm 995491 - Disclosure - Note 6 - Leases - Future Minimum Lease Payments Under ASC 842 (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases-future-minimum-lease-payments-under-asc-842-details Note 6 - Leases - Future Minimum Lease Payments Under ASC 842 (Details) Details 47 false false R48.htm 995492 - Disclosure - Note 6 - Leases - Future Minimum Lease Payments to be Received (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases-future-minimum-lease-payments-to-be-received-details Note 6 - Leases - Future Minimum Lease Payments to be Received (Details) Details 48 false false R49.htm 995493 - Disclosure - Note 6 - Leases - Supplemental Cash Flow Information Related to Leases (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-6-leases-supplemental-cash-flow-information-related-to-leases-details Note 6 - Leases - Supplemental Cash Flow Information Related to Leases (Details) Details 49 false false R50.htm 995494 - Disclosure - Note 7 - Intangible Assets - Intangible Assets, Net (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-7-intangible-assets-intangible-assets-net-details Note 7 - Intangible Assets - Intangible Assets, Net (Details) Details 50 false false R51.htm 995495 - Disclosure - Note 7 - Intangible Assets - Future Amortization Expense Maturity (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-7-intangible-assets-future-amortization-expense-maturity-details Note 7 - Intangible Assets - Future Amortization Expense Maturity (Details) Details 51 false false R52.htm 995496 - Disclosure - Note 8 - Accrued Expenses (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-8-accrued-expenses-details-textual Note 8 - Accrued Expenses (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-8-accrued-expenses-tables 52 false false R53.htm 995497 - Disclosure - Note 8 - Accrued Expenses - Composition of Current and Long-term Accrued Expenses (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-8-accrued-expenses-composition-of-current-and-longterm-accrued-expenses-details Note 8 - Accrued Expenses - Composition of Current and Long-term Accrued Expenses (Details) Details 53 false false R54.htm 995498 - Disclosure - Note 9 - Debt (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-details-textual Note 9 - Debt (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-tables 54 false false R55.htm 995499 - Disclosure - Note 9 - Debt - Schedule of Long Term Debt (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-schedule-of-long-term-debt-details Note 9 - Debt - Schedule of Long Term Debt (Details) Details 55 false false R56.htm 995500 - Disclosure - Note 9 - Debt - Schedule of Long Term Debt (Details) (Parentheticals) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-schedule-of-long-term-debt-details-parentheticals Note 9 - Debt - Schedule of Long Term Debt (Details) (Parentheticals) Details 56 false false R57.htm 995501 - Disclosure - Note 9 - Debt - Future Minimum Principal Payments (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-future-minimum-principal-payments-details Note 9 - Debt - Future Minimum Principal Payments (Details) Details 57 false false R58.htm 995502 - Disclosure - Note 9 - Debt - Schedule of Debt Issuance Costs and Discounts (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-9-debt-schedule-of-debt-issuance-costs-and-discounts-details Note 9 - Debt - Schedule of Debt Issuance Costs and Discounts (Details) Details 58 false false R59.htm 995503 - Disclosure - Note 10 - Stockholders' Equity (Deficit) (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-details-textual Note 10 - Stockholders' Equity (Deficit) (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables 59 false false R60.htm 995504 - Disclosure - Note 10 - Stockholders' Equity (Deficit) - Fair Value Options Weighted-Average Assumptions (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-fair-value-options-weightedaverage-assumptions-details Note 10 - Stockholders' Equity (Deficit) - Fair Value Options Weighted-Average Assumptions (Details) Details http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables 60 false false R61.htm 995505 - Disclosure - Note 10 - Stockholders' Deficit (Deficit) - Options Award Assumptions (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-deficit-deficit-options-award-assumptions-details Note 10 - Stockholders' Deficit (Deficit) - Options Award Assumptions (Details) Details 61 false false R62.htm 995506 - Disclosure - Note 10 - Stockholders' Equity (Deficit) - Stock-based Compensation Expense (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-stockbased-compensation-expense-details Note 10 - Stockholders' Equity (Deficit) - Stock-based Compensation Expense (Details) Details http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables 62 false false R63.htm 995507 - Disclosure - Note 10 - Stockholders' Equity (Deficit) - Stock Option Activity (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-stock-option-activity-details Note 10 - Stockholders' Equity (Deficit) - Stock Option Activity (Details) Details http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables 63 false false R64.htm 995508 - Disclosure - Note 10 - Stockholders' Equity (Deficit) - Stock Options Rollforward (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-stock-options-rollforward-details Note 10 - Stockholders' Equity (Deficit) - Stock Options Rollforward (Details) Details http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables 64 false false R65.htm 995509 - Disclosure - Note 10 - Stockholders' Equity (Deficit) - Restricted Stock Units (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-restricted-stock-units-details Note 10 - Stockholders' Equity (Deficit) - Restricted Stock Units (Details) Details http://www.pumabiotechnology.com/20231231/role/statement-note-10-stockholders-equity-deficit-tables 65 false false R66.htm 995510 - Disclosure - Note 11 - 401(k) Savings Plan (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-11-401k-savings-plan-details-textual Note 11 - 401(k) Savings Plan (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-11-401k-savings-plan 66 false false R67.htm 995511 - Disclosure - Note 12 - Income Taxes (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-details-textual Note 12 - Income Taxes (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-tables 67 false false R68.htm 995512 - Disclosure - Note 12 - Income Taxes - Schedule of Income Tax Expense (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-schedule-of-income-tax-expense-details Note 12 - Income Taxes - Schedule of Income Tax Expense (Details) Details 68 false false R69.htm 995513 - Disclosure - Note 12 - Income Taxes - Schedule of Income Tax Reconciliation (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-schedule-of-income-tax-reconciliation-details Note 12 - Income Taxes - Schedule of Income Tax Reconciliation (Details) Details 69 false false R70.htm 995514 - Disclosure - Note 12 - Income Taxes - Components of Net Deferred Tax Assets (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-components-of-net-deferred-tax-assets-details Note 12 - Income Taxes - Components of Net Deferred Tax Assets (Details) Details 70 false false R71.htm 995515 - Disclosure - Note 12 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-12-income-taxes-reconciliation-of-unrecognized-tax-benefits-details Note 12 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) Details 71 false false R72.htm 995516 - Disclosure - Note 13 - Commitments and Contingencies (Details Textual) Sheet http://www.pumabiotechnology.com/20231231/role/statement-note-13-commitments-and-contingencies-details-textual Note 13 - Commitments and Contingencies (Details Textual) Details http://www.pumabiotechnology.com/20231231/role/statement-note-13-commitments-and-contingencies 72 false false All Reports Book All Reports pbyi-20231231.xsd pbyi-20231231_cal.xml pbyi-20231231_def.xml pbyi-20231231_lab.xml pbyi-20231231_pre.xml pbyi20231231_10k.htm pipeline22424rdg.jpg yearperfsized4.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true